Overview
We have carefully chosen a varied group of potential mentors for fellows. The faculty are world-renowned scientists in varied areas of gynecologic oncology research.
Each of the mentors has supervised many previous graduate students and post-doctoral fellows.
Fellows are expected to participate in departmental seminars, laboratory meetings and other educational experiences (research retreats, etc.) that are part of that mentor's training program.
Although the mentors are affiliated with a variety of outside departments, they have served as mentors to postdoctoral fellows on our department's Women's Reproductive Health Research (WRHR) training grant since 1999.
Thus, these specific mentors already have strong ties to our department and were selected from among many researchers in gynecologic cancers at both UW and FHCRC because of their previous experience successfully training clinical fellows in ob/gyn research.
Research mentors
The current list of research mentors, all of whom have joint appointments at both FHCRC and the UW, includes:
- Mary (Nora) Disis, MD, Professor, Department of Medicine (UW/FHCRC)
- David Flum, MD, MPH, Professor, Departments of Surgery and Public Health (UW)
- Denise Galloway, PhD, Professor, Microbiology (UW)
- Stephen Hawes, MS, PhD, Associate Professor, Epidemiology (UW)
- Mary-Claire King, PhD, Professor, Departments of Medicine & Genome Sciences (UW)
- Christopher Li, MD, PhD, Professor, Epidemiology (UW)
- Mary Ann Rossing, PhD, DVM, Associate Member, Public Health Sciences (FHCRC)
- Elizabeth Swisher, MD, Professor, Director, Gynecologic Oncology, Department of Obstetrics and Gynecology (UW)
- Nicole Urban, PhD, Program Head, Gynecologic Cancer Research Program (FHCRC)
Recent Fellow Thesis projects
- Isabel Rodriguez, MD (2024) - Development and Validation of a Quantitative Assay to Identify and Characterize BRCA1 and RAD51C Methylated Ovarian Carcinoma
- Talayeh Ghezelayagh, MD, MPH (2023) - Evaluation of TP53 mutations in Pap test and blood DNA as novel biomarkers of ovarian cancer risk
- Leeya F. Pinder, MD (2022) - Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya
- Soledad Jorge, MD (2021) - Characterization of the Early Years of Bevacizumab Use for First Line Treatment of Ovarian Cancer in the United States
- Christopher Brooks Morse, MD (2020) - Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micrometastatic disease
- Emily Shuyi Wu, MD (2019) - The association between HIV infection and cervical cancer presentation and survival in Uganda
- Jovana Yanique Martin, MD (2018) - Preventive healthcare utilization among with endometrial cancer in the survivorship period
- Tiffany Lee Beck, MD (2017) - Robotic Assisted Surgery Compared with Laparoscopy and Laparotomy in the Treatment of Endometrial Cancer in Washington State, 2008-2011
- Minh Duy Dao, MD (2016) - Serum antibodies recognizing hypoxia-inducible factor 1-alpha and p53 predict platinum sensitivity in ovarian cancer
- Kathryn Pennington, MD (2015) - The Fanconi anemia-BRCA pathway in ovarian carcinoma